|
Forskningsnytt om olanzapine (010309)
Nyligen publicerades en mängd artiklar om den antispykotiska
substansen olanzapine, kommersiellt känd som Zyprexa. Nedan
följer en lista med länkar till PubMed abstrakt för
dessa. Samtliga artiklar är från The
Journal of Clinical Psychiatry 2001 Vol 62 Suppl 2.
Superior
efficacy of olanzapine over haloperidol: analysis of patients with
schizophrenia from a multicenter international trial.
Effective
resolution with olanzapine of acute presentation of behavioral agitation
and positive psychotic symptoms in schizophrenia.
The
efficacy of a rapid-acting intramuscular formulation of olanzapine
for positive symptoms.
An
efficacy analysis of olanzapine treatment data in schizophrenia
patients with catatonic signs and symptoms.
An
efficacy analysis of olanzapine treatment data in schizophrenia
patients with catatonic signs and symptoms.
Evidence
for the effectiveness of olanzapine among patients nonresponsive
and/or intolerant to risperidone.
Cardiac
safety parameters of olanzapine: comparison with other atypical
and typical antipsychotics.
I Pharmacoeconomics i december 2000 publicerades även en artikel
om olanzapinebehandling ur klinisk och ekonomisk synvinkel:
Olanzapine
versus risperidone. A prospective comparison of clinical and economic
outcomes in schizophrenia.
|
